| （単位：千ドル） | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 | 2Q25 | 3Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 273 | 715 | 212 | 915 | 1,223 | 1,869 | 1,089 | 1,270 | 1,062 | 748 | 1,314 | 1,220 | 638 |
| 営業費用 | 552 | 1,554 | 1,071 | 1,879 | 2,612 | 3,813 | 2,864 | 2,543 | 2,760 | 1,664 | 2,412 | 2,588 | 1,892 |
| 営業利益 | - | - | -1,072 | -1,880 | -2,613 | -3,814 | -2,865 | -2,544 | -2,761 | -1,665 | -2,413 | -2,589 | -1,893 |
| 経常（税引前）利益 | -556 | -1,555 | - | - | - | - | - | - | - | - | - | - | - |
| 純利益 | -556 | -1,554 | -1,073 | -1,877 | -2,612 | -3,827 | -2,798 | -2,500 | -2,718 | -1,654 | -2,200 | -2,464 | -1,677 |
| 一株あたり利益 | - | - | - | - | -0.11 | -0.15 | -0.11 | -0.1 | -0.11 | -0.06 | -0.08 | -0.09 | -0.04 |
| 希薄化後一株あたり利益 | - | - | - | - | -0.11 | -0.15 | -0.11 | -0.1 | -0.11 | -0.06 | -0.08 | -0.09 | -0.04 |